Stephan M.
- Country
- Germany
- Department
- Clinic for Dermatology
Research Overview
- Efficacy and Safety Evaluation of JNJ-77242113 Versus Placebo and Deucravacitinib in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Controlled Trial
- Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: An Open-label Extension Study
- Evaluation of Lebrikizumab Efficacy and Safety in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Phase 3b Open-label Study
Data & Insights
Has run more than one trial at 75 of 246 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating moderate to severe plaque psoriasis, conducting extensive research into novel therapeutic approaches for this chronic inflammatory condition.
- Plaque Psoriasis Management
- Long-term Disease Control
- Treatment Response Assessment
Their work includes evaluating innovative treatment options and monitoring long-term safety profiles in psoriasis care.
Autoimmune Dermatology
Focused on advancing treatment for cutaneous lupus erythematosus and bullous pemphigoid, with particular attention to cases resistant to conventional therapies.
- Subacute and Chronic Cutaneous Lupus
- Bullous Pemphigoid Treatment
- Autoimmune Skin Disease Management
The investigator explores novel therapeutic approaches for complex autoimmune dermatological conditions.
Allergic Skin Disorders
Expertise in treating chronic urticaria and atopic dermatitis, investigating both spontaneous and inducible forms of these conditions.
- Chronic Spontaneous Urticaria
- Chronic Inducible Urticaria
- Moderate to Severe Atopic Dermatitis
Their research encompasses various therapeutic approaches for allergic skin manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.